Latest News & Features
Asia
Indian drug maker Cipla has signed a deal with Salix Pharmaceuticals allowing the US-based company exclusive rights relating to the Rifaximin Complexes patent family. 19 September 2014
Asia
US biotechnology company Gilead has agreed a licensing deal with seven Indian drug makers that will enable them to sell a generic version of a drug used to treat hepatitis C. 17 September 2014
Asia
Biopharmaceutical company Epirus has said that India’s drug regulator has approved a biosimilar application to produce a version of a popular arthritis treatment drug. 16 September 2014
Big Pharma
A newly revealed malware could be looking to attack the pharmaceutical sector in order to steal IP, a report has claimed. 15 September 2014
Americas
Law firm Kilpatrick Townsend & Stockton LLP has bolstered its Californian team with the appointment of a new pharmaceutical IP specialist. 12 September 2014
Big Pharma
UK-based law firm Carpmaels & Ransford LLP has announced the appointment of two new partners to its London office. 11 September 2014
Americas
Bristol-Myers Squibb has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer. 10 September 2014
Asia-Pacific
The Australian government department responsible for IP has suggested abolishing a committee that looks after plant breeders’ rights as it looks at alternative means for giving advice to breeders. 9 September 2014
Asia-Pacific
Companies in Australia will be able to continue to patent human genes after a court rejected an appeal by a breast cancer survivor. 8 September 2014
Americas
Magistrate judge Christopher Burke has recommended that the US District Court for the District of Delaware affirm a motion to dismiss a patent infringement case related to the patent eligibility of subject matter, as laid out in 35 USC §101. 5 September 2014